BlackRock Institutional Trust’s BioAmber Inc. BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$757K Hold
137,711
﹤0.01% 3365
2016
Q3
$584K Hold
137,711
﹤0.01% 3450
2016
Q2
$410K Hold
137,711
﹤0.01% 3540
2016
Q1
$578K Hold
137,711
﹤0.01% 3421
2015
Q4
$851K Hold
137,711
﹤0.01% 3367
2015
Q3
$737K Buy
137,711
+3,634
+3% +$24K ﹤0.01% 3420
2015
Q2
$1.15M Buy
134,077
+7,861
+6% +$71.9K ﹤0.01% 3323
2015
Q1
$1.1M Buy
126,216
+15,996
+15% +$141K ﹤0.01% 3316
2014
Q4
$925K Buy
110,220
+7,882
+8% +$71.7K ﹤0.01% 3378
2014
Q3
$1.02M Buy
102,338
+17,350
+20% +$203K ﹤0.01% 3318
2014
Q2
$846K Buy
84,988
+17,687
+26% +$183K ﹤0.01% 3480
2014
Q1
$770K Buy
67,301
+42,880
+176% +$508K ﹤0.01% 3491
2013
Q4
$183K Buy
24,421
+23,856
+4,222% +$163K ﹤0.01% 3730
2013
Q3
$3K Hold
565
﹤0.01% 3929
2013
Q2
$4K Buy
+565
New +$4.2K ﹤0.01% 3942

Other funds holding BIOA

BlackRock Institutional Trust's BIOA Position: Q4 2016 in Review

BlackRock Institutional Trust held its BioAmber Inc. (BIOA) position steady in Q4 2016 at 137,711 shares worth $757K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

BlackRock Institutional Trust first reported a position in BIOA in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.15M in Q2 2015. 32 funds tracked by Wall St. Rank hold BIOA as of Q4 2016.

  • BlackRock Institutional Trust held 137,711 shares of BioAmber Inc. worth $757K as of Q4 2016.
  • BlackRock Institutional Trust left its BioAmber Inc. share count unchanged in Q4 2016.
  • BioAmber Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3365 holding.
  • BlackRock Institutional Trust first reported a position in BioAmber Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's BioAmber Inc. position peaked at $1.15M in Q2 2015.
  • 32 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.